HOME Top Market Reports Next Generation Sequencing (NGS) Market by Platforms (Illumina HiSeq, MiSeq, HiSeqX Ten, NextSeq 500,Thermo Fisher Ion Proton/PGM), Bioinformatics (Exome Sequencing, RNA-Seq, ChIP-Seq), Technology (SBS, SMRT) & by Application (Diagnostics, Personalized Medicine) – Global Forecast to 2020

Next Generation Sequencing (NGS) Market by Platforms (Illumina HiSeq, MiSeq, HiSeqX Ten, NextSeq 500,Thermo Fisher Ion Proton/PGM), Bioinformatics (Exome Sequencing, RNA-Seq, ChIP-Seq), Technology (SBS, SMRT) & by Application (Diagnostics, Personalized Medicine) – Global Forecast to 2020

By: marketsandmarkets.com
Publishing Date: September 2014
Report Code: BT 2697

 

  Speak to Analyst Enquiry Before Buying
 
purchase report
download pdf  request for customisation


The next generation sequencing market is rapidly evolving with a large number of developments taking place to increase accuracy and speed, and reduce costs of sequencing. It is the fastest-growing and most lucrative segment in the genomics space with an estimated growth of 23.1%. The global NGS market will be worth $2.5 billion in 2014 and is poised to reach $8.7 billion by 2020. By supporting genomics research, various government bodies like NHGRI (National Human Genome Research Institute, U.S.) and Biotechnology and Biological Sciences Research Council (BBSRC, U.K.) are increasing the adoption of high-throughput sequencing platforms.

The growth of the overall next generation sequencing market is driven by continuous innovations and developments in the market aimed at higher throughput, increased accuracy, and affordable costs. However, factors such as high reliability on grants and funding from the government, and decrease in capital expenditure from academic institutions are hindering the growth of the market. In addition, the interpretation of big data generated by sequencers and the subsequent storage and management of the analyzed data is still a challenge. Owing to the complexity of NGS technologies and data, standardization of the overall NGS workflow presents an unmet need. The opportunities for the growth of this market include developments in the pre-sequencing, cloud computing, and NGS bioinformatics solutions.

The NGS platforms market will be dominated by Illumina in 2014, which will occupy the largest market share of 74%. Other companies with commercial platforms include Life Technologies (Thermo Fisher Scientific) (U.S.), 454 Roche (U.S.), and Pacific Biosciences (U.S.). The recently introduced platforms such as HiSeq X Ten and NextSeq 500 will drive the market. Based on steps in the NGS workflow, the overall next generation sequencing market has three major segments, namely, pre-sequencing, NGS platforms and services, and NGS data analysis, storage and management.

The raw sequencing data generated by today’s sequencers does not reflect on any meaningful information in itself. Also, open source tools for analyzing NGS data require adequate bioinformatics training. These factors open up huge opportunities for commercial NGS bioinformatics software, workbenches, and services, whose market is currently fragmented and has a relatively smaller size. Whole genome sequencing, exome sequencing, targeted re-sequencing, de novo sequencing, RNA-Seq, ChIP-Seq and methyl-Seq are the major applications that use NGS data analysis tools and services. Key players such as CLC bio (A member of QIAGEN) (The Netherlands), Biomatters (New Zealand), Partek (U.S.), Genomatix (Germany), Knome (U.S.), and DNASTAR (U.S.) dominate this market space.

Next generation sequencing is set to revolutionize applied markets such as diagnostics, drug discovery, biomarker discovery, personalized medicine, and agriculture and animals research. Research institutes and government bodies contribute the highest to the end-user market of NGS; however, the adoption rate in hospitals will increase in the near future owing to cost effectiveness, increasing applications in diagnostics, high throughput, and sensitivity.

The next generation sequencing market will witness a whole new generation of sequencing platforms based on nanopore sequencing technology and fully integrated instruments in a few years that could perform all the NGS workflow steps.

Scope of the Report

This research report categorizes and analyzes the global next generation sequencing market on the basis of steps in the NGS workflow and applications. These markets are further divided into segments and sub-segments, to provide exhaustive value analysis for the years 2012, 2013, and 2014 forecast to 2020. Each market is comprehensively analyzed at a granular level by geography (North America, Europe, Asia, and Rest of the World) to provide in-depth information on the global scenario.

B steps in workflow

  • Pre-sequencing Products and Services
    • DNA fragmentation and size selection
    • Library preparation
    • Target enrichment
    • Quality control
  • Sequencing Platforms, Consumables/Reagents and Services
    • Illumina
      • HiSeq Series
      • HiSeq X Ten
      • NextSeq
      • Genome Analyzer IIx
      • MiSeq
  • Life Technologies (Thermo Fisher Scientific)
    • SOLiD Series
    • Ion PGM (Personal Genome Machine)
    • Ion Proton
  • 454 Lifesciences (Roche)
    • GS Junior
    • GS FLX+
  • Pacific Biosciences
    • PacBio RS II
  • Sequencing Services
  • NGS Data Analysis/Bioinformatics
    • By product
      • NGS data analysis software and workbenches
      • NGS data analysis services
      • NGS storage management and cloud computing solutions
    • By application
      • Whole Genome Sequencing
      • Exome Sequencing
      • Targeted Resequencing
      • De novo Sequencing
      • RNA-Seq
      • ChIP-Seq
      • Methyl-Seq
      • Others

B Technology

  • Sequencing by synthesis (SBS)
  • Ion semiconductor sequencing
  • Sequencing by ligation (SBL)
  • Pyrosequencing
  • Single molecule, real-time (SMRT) Sequencing

B Application

  • Diagnostics
  • Drug Discovery
  • Biomarker Discovery
  • Personalized Medicine
  • Agriculture and Animal Research
  • Others

B Geography

  • North America
  • Europe
  • Asia
  • RoW (Africa, LATAM, Middle-East, Pacific countries)

Table of Contents 
 
1 Introduction (Page No. - 21)
  1.1 Objectives Of The Study
  1.2 Markets Covered
  1.3 Stakeholders
  1.4 Market Scope

2 Research Methodology (Page No. - 25)
  2.1 Market Size Estimation
  2.2 Market Crackdown And Data Triangulation
  2.3 Market Share Estimation
      2.3.1 Key Data From Secondary Sources
      2.3.2 Key Data From Primary Sources
      2.3.3 Assumptions
            2.3.3.1 Key Industry Insights

3 Executive Summary (Page No. - 31)

4 Premium Insights (Page No. - 35)
  4.1 Attractive Market Opportunities In The Next-Generation Sequencing (NGS) Market
  4.3 Nxt Generation sequencing Market, By Product Segment
  4.4 NGS Platform Market Size (Units)
  4.5 NGS Market Growth Opportunities, By Geography
  4.6 Life Cycle Analysis, By Geography
  4.7 NGS Market In Asian Region
  4.8 Company Market Share Analysis, By Geography
  4.9 NGS Market, By Application

5 Market Overview (Page No. - 43)
  5.1 Introduction
  5.2 Evolution
  5.3 Market Segmentation
  5.4 Market Dynamics
      5.4.1 Drivers
            5.4.1.1 Cost And Speed To Drive The Growth Of NGS Technology
            5.4.1.2 Substitution Of Microarray Technology By NGS To Boost Market Growth
            5.4.1.3 Embracement Of NGS Technology By New Consumers To Propel The Market
            5.4.1.4 Increase In Practice For New Scientific Applications To Boost Growth Of NGS Market
            5.4.1.5 Research Laboratories And Academicians Promoting NGS
            5.4.1.6 Global Alliances AmoNGSt Leading Research Institutes To Trigger Drug Discovery, Thus Increase The Demand Of NGS
            5.4.1.7 Entry Of New Players Propelling The Growth Of The NGS Market
      5.4.2 Restraints
            5.4.2.1 High Reliability On Grants To Restrict Growth
            5.4.2.2 Decrease In Capital Expenditure From Academic Institutes To Hinder The Sale Of Platforms
            5.4.2.3 Accuracy & Standardization Concerns In Diagnostic Testing
            5.4.2.4 Ethical And Legal Issues Related To Next-Generation Sequencing To Hinder The Adoption, Albeit To A Less Extent
       5.4.3 Opportunities
             5.4.3.1 Personalized Medicine & Biomarker Discovery Open Avenues For Investments In NGS Technology
             5.4.3.2 Pre-Sequencing A High Growth Opportunity
             5.4.3.3 Cloud Computing, A Prospective Service
       5.4.4 Challenges
             5.4.4.1 Interpretation Of Complex Data From NGS Platforms
       5.4.5 Market Trend
             5.4.5.1 Shift Of Focus Towards Third-Generation Sequencing
       5.4.6 Burning Issues
             5.4.6.1 Data Storage An Impediment To NGS Sequencing
             5.4.6.2 Reduction In Cost To Sequence Human Genomes
        5.4.7 Winning Imperative
              5.4.7.1 Improved Collaborative Ties Between Industry And Academic & Research Institutes

6 Industry Trends (Page No. - 56)
  6.1 Value Chain Analysis
  6.2 Porter’s Five Forces Analysis
      6.2.1 Threat From New Entrants
      6.2.2 Threat From Substitutes
      6.2.3 Bargaining Power Of Buyers
      6.2.4 Bargaining Power Of Suppliers
      6.2.5 Competitive Rivalry Among Exisiting Firms
  6.3 Technological Development Road-Map
      6.3.1 Sanger Sequencing
      6.3.2 Massively Parallel Sequencing (Next Generation Sequencing)
      6.3.3 Single Molecule Real Time (Smrt) Sequencing
      6.3.4 Nanopore Sequencing
  6.4 Technological Trends
      6.4.1 Nanopore Sequencing Technology
            6.4.1.1 Oxford Nanopore Technologies
            6.4.1.2 Roche (Genia Technologies)
                    6.4.1.3 Electronic Biosciences
      6.4.2 Sequencing By Hybridization Technology (Gnubio)
      6.4.3 Genius (Gene Electronic Nano-Integrated Ultra-Sensitive) Technology (Genapsys)
      6.4.4 Lightning Terminator Sequencing Technology (Lasergen)
      6.4.5 Optical Nanopore Sequencing Technology (Noblegen) 
      6.4.6 Nanowire Biosensor Sequencing Technology (Quantumdx)

7 Global NGS Market, By Steps In Workflow (Page No. - 61)
  7.1 Introduction
  7.2 Pre-Sequencing Products & Services Market
      7.2.1 Sample Preparation
            7.2.1.1 DNA Fragmentation, End Repair, A-Tailing And Size Selection
            7.2.1.2 Library Preparation
            7.2.1.3 Target Enrichment
            7.2.1.4 Quality Control
  7.3 Sequencing Platforms Market
      7.3.1 Illumina
            7.3.1.1 Hiseq Series
            7.3.1.2 Hiseq X Ten
            7.3.1.3 Genome Analyzer Iix
                    7.3.1.3.1 Low Technological Advancements Will Result Into Downfall Of Ga Iix
            7.3.1.4 Miseq
            7.3.1.5 Nextseq500
      7.3.2 Thermo Fisher Scientific (Life Technologies)
            7.3.2.1 Solid Series
                    7.3.2.1.1 Solid Series Shows Minimal Scope For Growth
            7.3.2.2 Ion Torrent Platforms
                    7.3.2.2.1 Ion Torrent Pgm
                              7.3.2.2.1.1 Currently Ion Torrent Pgm Exceeds The Unit Sales As Compared To Its Competitor Miseq
                    7.3.2.2.2 Ion Proton
                              7.3.2.2.2.1 Ion Proton Will Be One Of The Fast Growing Platforms
      7.3.3 454 Roche
            7.3.3.1 GS Junior Sales Stopped In 2013 And GS Flx+ Will Grow At Slow Pace Till 2016
            7.3.3.2 GS Junior
            7.3.3.3 GS Flx+
      7.3.4 Pacific Biosciences
            7.3.4.1 Pacbio Rs Ii
  7.4 Sequencing Services Market
  7.5 NGS Data Analysis, Storage, And Management (Bioinformatics) Market
      7.5.1 Open-Source Applications Contribute 75% To The Overall NGS Bioinformatics Solutions Market
      7.5.2 NGS Data Analysis, By Product
            7.5.2.1 NGS Data Analysis Software & Workbenches
            7.5.2.2 NGS Data Analysis Services
      7.5.3 NGS Data Analysis, By Application
            7.5.3.1 Whole-Genome Sequencing
            7.5.3.2 Exome Sequencing
            7.5.3.3 Targeted Re-Sequencing
            7.5.3.4 De Novo Sequencing
            7.5.3.5 RNA-Seq
            7.5.3.6 Chip-Seq
            7.5.3.7 Methyl-Seq
            7.5.3.8 Others
      7.5.4 NGS Storage, Management & Cloud Computing Solutions

8 Next Generation Sequencing Market, By Technology (Page No. - 109)
  8.1 Introduction
  8.2 Sequencing By Synthesis (Sbs)
      8.2.1 Sbs To Be The Fastest-Growing Technology
  8.3 Ion Semiconductor Sequencing
      8.3.1 Ion Semiconductor Sequencing, A Fast-Growing Market
  8.4 Sequencing By Ligation (Sbl)
      8.4.1 Sbl Technology To Witness Negative Growth
  8.5 Pyrosequencing
      8.5.1 Pyrosequencing To Grow At A Negative Rate
  8.6 Single Molecule Realtime Sequencing (Smrt)
      8.6.1 Smrt Technology Has Limited Applications

9 Global NGS Application Market (Page No. - 117)
  9.1 Introduction
  9.2 Diagnostics
      9.2.1 Diagnostics Market Will Grow With Addition Of Wider Applications
      9.2.2 Cancer Diagnostics To Drive The Market
  9.3 Drug Discovery
      9.3.1 Focus On Targeted Therapy To Boost The Next Generation Sequencing Market
  9.4 Biomarker Discovery
      9.4.1 Biomarker Discovery Application To Grow At A High Rate
  9.5 Personalized Medicine
      9.5.1 Personalized Medicine Offers Huge Potential Market
  9.6 Agriculture & Animal Research
      9.6.1 Applications In Crop Research & Animal Biotechnology To Boost The Next Generation Sequencing Market
  9.7 Other Applications (Marine Research, Research In Bio-Fuels, Forensic Medicine, Phyleogeograpic & Phylogenetic Studies)

10 Next Generation Sequencing Market, By End-User (Page No. - 126)
  10.1 Introduction
       10.1.1 Research Centers, Academic & Government Institutes
              10.1.1.1 NGS Is A Research-Driven Market, Hence Highest Market Share
       10.1.2 Hospitals & Clinics
              10.1.2.1 Segment To Show Highest Growth Rate
       10.1.3 Pharmaceutical & Biotechnology Companies
              10.1.3.1 Targeted Therapy, Biomarker Research To Boost Segment Growth
       10.1.4 Other End-Users (Npo, Agrigenomics Organizations, Consumer Genomic Companies)

11 Next Generation Sequencing Market, By Geography (Page No. - 133)
   11.1 Introduction
   11.2 North America
        11.2.1 Government Funding To Boost The U.S. Market
        11.2.2 Funds By Canadian Government Strives To Boost Next Generation Sequencing Market
   11.3 Europe
        11.3.1 Germany,U.K., And Belgium Are The Hubs For Scientific Research
        11.3.2 Investments In Rare Disease Research Likely To Boost The NGS Market In Europe
        11.3.3 Increasing Funding For Molecular Diagnostics In Europe Is Likely To Propel The Growth Of The Whole Exome Sequencing Market
   11.4 Asia
        11.4.1 China: Lucrative Market For NGS Products And Services Market
        11.4.2 Regular Funding From The Indian Government, An Impetus To The NGS Market
   11.5 Rest Of The World (Row)
        11.5.1 Bioinformatics & Biotechnology Research In Latin America To Boost The Demand For NGS Instruments & Services
        11.5.2 Flourishing Bio-Research Centers & Financial Support In Australia & Brazil Will Propel The Market

12 Competitive Landscape (Page No. - 162)
  12.1 Overview
  12.2 Market Share Analysis
       12.2.1 Global NGS Platform Market
  12.3 New Product Launches
  12.4 Agreements And Partnerships
  12.5 Mergers & Acquisitions
  12.6 Expansions

13 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)* (Page No. - 172)
   13.1 Introduction
   13.2 454 Life Sciences Corporation (Roche Holding Ag)
        13.2.1 Business Overview
        13.2.2 Financials
        13.2.3 Products & Services
        13.2.4 Strategy
        13.2.5 Recent Developments
   13.3 Agilent Technologies, Inc.
       13.3.1 Business Overview
       13.3.2 Financials
       13.3.3 Products And Services
       13.3.4 Key Strategy
       13.3.5 Recent Developments
   13.4 Bgi (Beijing Genomics Institute)
       13.4.1 Business Overview
       13.4.2 Financials
       13.4.3 Products & Services
       13.4.4 Key Strategy
       13.4.5 Recent Developments
   13.5 Biomatters, Ltd.
        13.5.1 Business Overview
        13.5.2 Financials
        13.5.3 Products & Services
        13.5.4 Key Strategy
        13.5.5 Recent Developments
   13.6 Clc Bio (Acquired By Qiagen)
        13.6.1 Business Overview
        13.6.2 Financials
        13.6.3 Products & Services
        13.6.4 Key Strategy
        13.6.5 Recent Developments
   13.7 Dnastar, Inc.
        13.7.1 Business Overview
        13.7.2 Financials
        13.7.3 Products & Services
        13.7.4 Key Strategy
        13.7.5 Recent Developments  
   13.8 Gatc Biotech Ag
        13.8.1 Business Overview
        13.8.2 Financials
        13.8.3 Products & Services
        13.8.4 Key Strategy
        13.8.5 Recent Developments
   13.9 Genomatix Software Gmbh
        13.9.1 Business Overview
        13.9.2 Financials
        13.9.3 Products & Services
        13.9.4 Key Strategy
        13.9.5 Recent Developments
   13.1 Illumina, Inc.
        13.10.1 Business Overview
        13.10.2 Financials
        13.10.3 Products & Services
        13.10.4 Key Strategy
        13.10.5 Recent Developments
        13.10.6 Swot
        13.10.7 Mnm View
   13.11 Knome, Inc.
         13.11.1 Business Overview
         13.11.2 Financials
         13.11.3 Products & Services
         13.11.4 Key Strategy
         13.11.5 Recent Developments
   13.12 Life Technologies Corporation (Thermo Fisher Scientific)
         13.12.1 Business Overview
         13.12.2 Financials
         13.12.3 Products & Services
         13.12.4 Key Strategy
         13.12.5 Recent Developments
         13.12.6 Swot
         13.12.7 Mnm View
   13.13 Macrogen, Inc.
         13.13.1 Business Overview
         13.13.2 Financials
         13.13.3 Products & Services
         13.13.4 Key Strategy
         13.13.5 Recent Developments  
   13.14 Oxford Nanopore Technologies, Ltd.
         13.14.1 Overview
         13.14.2 Financials
         13.14.3 Products & Services
         13.14.4 Key Strategy
         13.14.5 Recent Developments
   13.15 Pacific Biosciences
         13.15.1 Business Overview
         13.15.2 Financials
         13.15.3 Products & Services
         13.15.4 Key Strategy
         13.15.5 Recent Developments
         13.15.6 Swot
         13.15.7 Mnm View
   13.16 Partek Incorporated
         13.16.1 Business Overview
         13.16.2 Financials
         13.16.3 Products & Services
         13.16.4 Key Strategy
         13.16.5 Recent Developments
   13.17 Perkin Elmer, Inc.
         13.17.1 Business Overview
         13.17.2 Financials
         13.17.3 Products & Services
         13.17.4 Key Strategy
         13.17.5 Recent Developments
   13.18 Qiagen N.V.
         13.18.1 Business Overview
         13.18.2 Financials
         13.18.3 Products & Services
         13.18.4 Key Strategy
         13.18.5 Recent Developments
*Details On Financials, Product & Services, Strategy, & Developments Might Not Be Captured In Case Of Unlisted Companies. 
 
14 Appendix (Page No. - 233)
  14.1 Insights Of Industry Experts
  14.2 Discussion Guide
  14.3 Available Customizations
  14.4 Related Reports
  14.5 Introducing Rt: Real Time Market Intelligence

List Of Tables  (130 Tables)
 
Table 1 Overall Global Next Generation Sequencing Market, By Products & Services, 2012–2020 ($Million) 
Table 2 Technological Advancements, Decreasing Sequencing Costs Propelling Growth Of Next Generation Sequencing Market
Table 3 Comparison Between NGS & Microarray Systems
Table 4 Global Next Generation Sequencing Market Size, By Product, 2012–2020 ($Million)
Table 5 Next Generation Sequencing Market Size, By Geography, 2012 – 2020 ($Million)
Table 6 Global Pre-Sequencing Market, By Process, 2012 – 2020 ($Million)
Table 7 Next Generation Sequencing Market Size For Pre-Sequencing, By Geography, 2012–2020 ($Million) 
Table 8 Pre-Sequencing Market Size For Dna Fragmentation, End Repair, A-Tailing And Size Selection, By Geography, 2012-2020 ($Million) 
Table 9 Pre-Sequencing Market Size For Library Preparation, By Geography, 2012-2020 ($Million)
Table 10 Pre-Sequencing Market Size For Target Enrichment, By Geography 2012-2020 ($Million)
Table 11 Pre-Sequencing Market Size For Quality Control, By Geography, 2012-2020 ($Million) 
Table 12 Global Next Generation Sequencing Market Size For Instruments, Products And Services, 2012–2020 ($Million)
Table 13 NGS Platform Market, By Geography, 2012–2020 ($Million)
Table 14 Global NGS Market Size For Instruments, By Players, 2012–2020 ($Million) 
Table 15 Global Next Generation Sequencing Market Size For Instruments, By Players, 2012–2020 (No. Of Units Sold)
Table 16 Global Market Size For Platforms, By Brand, 2012–2020 ($Million)
Table 17 Global Market Size For Instruments, By Brand, 2012–2020 (No. Of Units)
Table 18 Global Market Size For Consumables, By Player, 2012–2020 ($Million) 
Table 19 Global Market Size For Post-Purchase Services, By Player, 2012–2020 ($Million) 
Table 20 Global Market Size For Illumina Platforms, 2012–2020 ($Million)
Table 21 Global Next Generation Sequencing Market Size For Illumina Platforms, By Product, 2012–2020 (No. Of Units) 
Table 22 Next Generation Sequencing Market Size For Illumina Platforms, By Geography, 2012–2020 ($Million) 
Table 23 Next Generation Sequencing Market Size For Illumina Consumables/Reagents Market, By Geography, 2012–2020 ($Million) 
Table 24 Market Size For Illumina Services, By Geography, 2012–2020 ($Million) 
Table 25 Hiseq Sequencing Instrument Market, By Geography, 2012–2020 ($Million) 
Table 26 Key End-Customer Of Hiseq X Ten In 2014
Table 27 Next Generation Sequencing Market Size For Hiseq X Ten Instrument, By Geography, 2012–2020 ($Million) 
Table 28 Market Size For Genome Analyzer Iix Sequencing Platform, By Geography, 2012–2020 ($Million) 
Table 29 Market Size For Miseq Platform, By Geography, 2012–2020 ($Million) 
Table 30 Market Size For Nextseq 500 Sequencing Platform, By Geography, 2012–2020 ($Million)
Table 31 Global Next Generation SequencingMarket Size For Thermo Fisher (Life Technologies), By Product, 2012–2020 ($Million) 
Table 32 Global Next Generation Sequencing Market Size For Thermo Fisher, By Brand, 2012–2020 (No. Of Units) 
Table 33 Next Generation Sequencing Market Size For Thermo Fisher Sequencing Platforms, By Geography, 2012–2020 ($Million) 
Table 34 Market Size For Thermo Fisher Consumables/Reagents, By Geography, 2012–2020 ($Million) 
Table 35 Market Size For Thermo Fisher Services, By Geography, 2012–2020 ($Million) 
Table 36 Market Size For Thermo Fisher Solid Series Instrument, By Geography, 2012–2020 ($Million) 
Table 37 Market Size For Thermo Fisher Ion Torrent Pgm Instrument, By Geography, 2012–2020 ($Million)
Table 38 Market Size For Thermo Fisher Ion Proton Instrument, By Geography, 2012-2020 ($Million) 
Table 39 Global Next Generation Sequencing Market Size For 454 Roche Platforms, 2012-2020, ($Million)
Table 40 454 Roche: NGS Platform Market, 2012–2020 (No. Of Units)
Table 41 454 Roche NGS Platform Market, By Geography, 2012–2020 ($Million)
Table 42 Next Generation Sequencing Market Size For 454 Roche Consumables/Reagents, By Geography, 2012–2020 ($Million)
Table 43 Market Size For 454 Roche Services, By Geography, 2012-2020 ($Million) 
Table 44 Gs Junior Market, By Geography, 2012–2020 ($Million)
Table 45 Gs Flx+ Market, By Geography, 2012–2020 ($Million)
Table 46 Pacific Biosciences: NGS Platforms Market, 2012–2020 ($Million)
Table 47 Pacific Biosciences: NGS Instrument Market, By Brand, 2012–2020 (No.Of Units) 
Table 48 Market Size For Pacific Biosciences Platforms, By Geography, 2012-2020 ($Million)
Table 49 Market Size For Pacific Biosciences Consumables/Reagents, By Geography, 2012-2020 ($Million)
Table 50 Market Size For Pacific Biosciences Services, By Geography, 2012-2020 ($Million) 
Table 51 Market Size For Pacbio Rs Ii Instruments, By Geography, 2012–2020 ($Million) 
Table 52 Global Next Generation Sequencing Market Size For Sequencing Services, By Application, 2012–2020 ($Million) 
Table 53 Next Generation Sequencing Market Size For Sequencing Services, By Geography, 2012-2020 ($Million) 
Table 54 Global Next Generation Sequencing Market Size For Data Analysis, By Products And Services, 2012–2020 ($Million)
Table 55 Market Size For Data Analysis, By Geography, 2012-2020 ($Million)
Table 56 Market Size For Data Analysis Software & Workbenches Products, By Geography, 2012-2020 ($Million)
Table 57 Global Next Generation Sequencing Market Size For Software & Workbenches, By Application, 2012-2020 ($Million)
Table 58 Next Generation Sequencing Market Size For Data Analysis Services, By Geography, 2012-2020 ($Million) 
Table 59 Global Next Generation Sequencing Market Size For Data Analysis Services, By Application, 2012-2020 ($Million)
Table 60 Global Market Size For Data Analysis, By Application, 2012-2020 ($Million)
Table 61 NGS Technologies, By Company
Table 62 Global Next Generation Sequencing Market Size, By Technology, 2012–2020 ($Million)
Table 63 Next Generation Sequencing Market Size For Sequencing By Synthesis Technology, By Geography, 2012–2020 ($Million) 
Table 64 Market Size For Ion Semiconductor Sequencing Technology, By Geography, 2012–2020 ($Million) 
Table 65 Next Generation Sequencing Market Size For Sequencing By Ligation Technology, By Geography, 2012–2020 ($Million)
Table 66 NGS Market Size For Pyrosequencing Technology, By Geography, 2012–2020 ($Million) 
Table 67 Market Size For Single Molecule Real Time Sequencing, By Geography, 2012–2020 ($Million)
Table 68 Global Next Generation Sequencing Market, By Application, 2012–2020 ($Million)
Table 69 Global Next Generation Sequencing Market Size For Diagnostics, By Geography, 2012–2020 ($Million) 
Table 70 NGS Market Size For Drug Discovery, By Geography, 2012–2020 ($Million) 
Table 71 NGS Market Size For Biomarker Discovery, By Geography, 2012–2020 ($Million) 
Table 72 Next Generation Sequencing Market Size For Personalized Medicine, By Geography, 2012–2020 ($Million) 
Table 73 NGS Market Size For Agriculture & Animal Research, By Geography, 2012 – 2020 ($Million)
Table 74 NGS Market Size For Other Applications, By Geography, 2012–2020 ($Million) 
Table 75 Global NGS Market, By End User, 2012-2020 ($Million)
Table 76 Next Generation Sequencing Market Size For Research Centers, Academic/Government Institutes Segment, By Geography, 2012-2020 ($Million)
Table 77 NGS Market Size For Hospitals & Clinics Segment, By Geography, 2012-2020 ($Million) 
Table 78 Next Generation Sequencing Market Size For Pharmaceutical & Biotechnology Companies, By Geography, 2012-2020 ($Million) 
Table 79 Market Size For Other End Users, By Geography, 2012-2020 ($Million) 
Table 80 Market Size, By Geography, 2012–2020 ($Million)
Table 81 Market Size For Pre-Sequencing, By Geography, 2012–2020 ($Million) 
Table 82 Market Size For Bioinformatics, By Geography, 2012–2020 ($Million) 
Table 83 Next Generation Sequencing Market Size Services, By Geography, 2012–2020 ($Million)
Table 84 North America: Next Generation Sequencing Market Size, Byproducts And Services, 2012–2020 ($Million) 
Table 85 North America: Market Size For Pre-Sequencing, By Product, 2012–2020 ($Million) 
Table 86 North America: Market Size For Platforms, By Company, 2012–2020 ($Million) 
Table 87 North America: Market Size For Illumina, By Product, 2012–2020 ($Million) 
Table 88 North America: Market Size For Thermo Fisher (Life Technologies), By Product, 2012–2020 ($Million)
Table 89 North America: Market Size For 454 Roche, By Product, 2012–2016 ($Million) 
Table 90 North America: Market Size For Pacific Biosciences, By Product, 2012–2020 ($Million)
Table 91 North America: Market Size For Bioinformatics, By Product, 2012–2020 ($Million) 
Table 92 North America: Market Size, By Technology, 2012–2020 ($Million)
Table 93 North America: Market Size, By Application, 2012–2020 ($Million)
Table 94 North America: NGS Market Size, By End User, 2012–2020 ($Million)
Table 95 Europe: Next Generation Sequencing Market Size, By Products And Services, 2012–2020 ($Million) 
Table 96 Europe: NGS Market Size For Pre-Sequencing, By Product, 2012–2020 ($Million) 
Table 97 Europe: Market Size For Platforms, By Company, 2012–2020 ($Million) 
Table 98 Europe: Market Size For Illumina, By Product, 2012–2020 ($Million)
Table 99 Europe: Market Size For Thermo Fisher (Life Technologies), By Product, 2012–2020 ($Million) 
Table 100 Europe: Market Size For 454 Roche, By Product, 2012–2020 ($Million) 
Table 101 Europe: Market Size For Pacific Biosciences, By Product, 2012–2020 ($Million) 
Table 102 Europe: Market Size For Bioinformatics, By Product, 2012–2020 ($Million) 
Table 103 Europe: Market Size, By Technology, 2012–2020 ($Million)
Table 104 Europe: Market Size, By Application, 2012–2020 ($Million)
Table 105 Europe: NGS Market Size, By End User, 2012–2020 ($Million)
Table 106 Asia: Next Generation Sequencing Market, Byproducts And Services, 2012–2020 ($Million)
Table 107 Asia: Market Size For Pre-Sequencing, By Product, 2012–2020 ($Million) 
Table 108 Asia: Market Size For Platforms, By Company, 2012–2020 ($Million)
Table 109 Asia: Market Size For Illumina, By Product, 2012–2020 ($Million)
Table 110 Asia: Market Size For Thermo Fisher (Life Technologies), By Product, 2012–2020 ($Million) 
Table 111 Asia: Next Generation Sequencing Market Size For 454 Roche, By Product, 2012–2016 ($Million)
Table 112 Asia: Market Size For Pacific Biosciences, By Product, 2012–2020 ($Million) 
Table 113 Asia: Market Size For Bioinformatics, By Product, 2012–2020 ($Million) 
Table 114 Asia: Market Size, By Technology, 2012–2020 ($Million)
Table 115 Asia: Market Size, By Application, 2012–2020 ($Million)
Table 116 Asia: NGS Market Size, By End User, 2012–2020 ($Million)
Table 117 Row: Next Generation Sequencing Market, By Products And Services, 2012–2020 ($Million)
Table 118 Row: Next Generation Sequencing Market Size For Pre-Sequencing, By Product, 2012–2020 ($Million) 
Table 119 Row: Market Size For Platforms, By Company, 2012–2020 ($Million)
Table 120 Row: Market Size For Illumina, By Product, 2014–2020 ($Million)
Table 121 Row: Market Size For Thermo Fisher (Life Technologies), By Product, 2012–2020 ($Million) 
Table 122 Row: Market Size For 454 Roche, By Product, 2012–2020 ($Million)
Table 123 Row: Market Size For Bioinformatics, By Product, 2012–2020 ($Million) 
Table 124 Row: Market Size, By Technology, 2012–2020 ($Million)
Table 125 Row: Market Size, By Application, 2012–2020 ($Million)
Table 126 Row: NGS Market Size, By End User, 2012–2020 ($Million)
Table 127 New Product Launches, 2012–2014
Table 128 Agreements And Partnerships, 2012–2014
Table 129 Mergers & Acquisitions, 2011–2014
Table 130 Expansion,2012-2014

 List of Figures  (52 Figures)
  
Figure 1 Research Methodology & Forecasting Model
Figure 2 Bottom-Up Approach
Figure 3 Top-Down Approach
Figure 4 Break Down Of Primary Interviews: By Company Type, Designation, And Region 
Figure 5 Opportunity Matrix: Consumables And Sequencing Services Provide Huge Opportunities In The Global NGS Market
Figure 6 NGS Platform Market Snapshot (2014 Vs. 2020): Platforms Using Sequencing By Synthesis Are Expected To Grow At The Fastest Rate
Figure 7 North America Dominates The Global Next Generation Sequencing Market
Figure 8 Attractive Market Opportunities In The Next Generation Sequencing Market
Figure 9 Consumables Segment To Grow At The Fastest Rate In The NGS Market
Figure 10 Ion Torrent Pgm & Miseq Platforms Are Sold The Most In 2014
Figure 11 Asia & North America Are The High Growth Markets For NGS
Figure 12 Developed Regions & Asia Both In Growth Phase Of The NGS Market
Figure 13 Sbs Technology Occupies The Largest Share Of The Asian Next Generation Sequencing Market
Figure 14 Illumina Leads The Next Generation Sequencing Market In All Regions
Figure 15 Diagnostics: A High-Value, High-Growth Rate Market In NGS
Figure 16 Evolution
Figure 17 Market Segmentation: By Product
Figure 18 Market Dynamics
Figure 19 Data Storage & Pricing, 1990 – 2012
Figure 20 Value Chain For Sequencing Platforms
Figure 21 Porter’s Five Forces Analysis
Figure 22 NGS Consumables Market Will Show Fastest Growth Owing To Increasing Installed Base Of Platforms
Figure 23 Pre-Sequencing Market: Library Preparation Segment Holds Largest Share
Figure 24 Global NGS Instruments Market Will Grow At A Cagr Of 15.4% From 2014-2020
Figure 25 Snapshot: NGS Platform Market, By Key Players (No. Of Units)
Figure 26 Illumina: Leader In The NGS Platform Market
Figure 27 Hiseq X Ten Revenues Poised To Overhaul Other Platforms Market, By 2020 
Figure 28 Hiseq X Ten To Grow The Fastest Amongst All Illumina Platforms
Figure 29 Miseq Sales To Cross 3,000 Units Per Year By 2020
Figure 30 North America To Grow The Fastest For Hiseq X Ten Platform
Figure 31 Ion Torrent Pgm Will Grow At The Highest Cagr By 2020
Figure 32 Pacific Biosciences NGS Market, 2014 Vs 2020 ($Million)
Figure 33 NGS Data Analysis Services Segment Will Grow Faster Than Software & Workbenches
Figure 34 NGS Techology Market, 2014 Vs. 2020 ($Million)
Figure 35 NGS Technology Market Size, By Geography, 2014–2020 ($Million)
Figure 36 Diagnostics Segment To Show Highest Growth
Figure 37 The Asian NGS Market Will Witness The Fastest Growth In Coming Years
Figure 38 Next-Generation Sequencing Market End-Users
Figure 39 Research Centers, Academic/Government Institutes Will Dominate End-User Segment
Figure 40 Asia-Pacific Next-Generation Sequencing Market Will Show Highest Growth
Figure 41 Geographic Snapshot (2014–2020): Asia And Latam Emerging As New Hot Spots
Figure 42 Next Generation Sequencing Market Size For Product Benchmarking, 2014–2020 (Cagr %)
Figure 43 North America NGS Market Snapshot: Illumina Holds Strong Position In The U.S. Market
Figure 44 Asia NGS Market Snapshot China Is The Lucrative Market
Figure 45 Companies Adopted New Product Launches As The Key Growth Strategy Over The Last Three Years
Figure 46 Global NGS Market Share Analysis, By Key Player, 2013
Figure 47 Global Next Generation Sequencing Platform Market Share Analysis, By Key Player, 2013 (No.Of Units) 
Figure 48 Global NGS Market Share Analysis, By Key Player, 2013 Vs. 2020
Figure 49 New Product Launches And Agreements & Partnerships Are The Highly Adopted Strategies For Growth Figure 50 Key Players Focusing On New Product Launches, 2011–2014
Figure 51 Key Players Focusing On Mergers And Acquisitions, 2011–2014
Figure 52 Geographic Revenue Mix Of Top Market Players

The next generation sequencing report (2014-2020) covers the market for pre-sequencing, sequencing platforms and bioinformatics tools and services. The NGS pre-sequencing (sample –preparation) segment represents a promising area in the overall market owing to the need for automation and standardized solutions for sample preparation. The market for sequencing platforms has been very dynamic. Some revolutionary platforms like GA IIx (Illumina) and SOLiD Series (Life Technologies) have taken a setback and newer platforms like HiSeq X Ten, NextSeq 500 and MiSeq are gaining market dominance. The next generation sequencing bioinformatics market comprises of software, workbenches, and services for the interpretation and analysis of data generated by sequencers, representing a lucrative market owing to better user interface and flexibility when compared to open-source tools.

The report also covers the market by applications, including drug discovery, clinical diagnostics, genomics, and proteomics. Along with large research and academic institutions that serve as a key end-user for the next generation sequencing market, NGS technologies are recently being developed for use in clinical set-ups and presently much of the NGS effort is focused on cancer.  

The factors driving the next generation sequencing market include decreasing costs, improved turnaround time, increase in number of applications, and replacement of microarray applications by NGS. Personalized medicine and biomarker discovery open avenues for investments, offering huge growth opportunities. However, the causes for hindrance to growth will be the high reliability on grants by research institutes, accuracy and standardization concerns, data storage problems, and issues in interpretation of complex data.

The global next generation sequencing market is geographically segmented into North America, Europe, Asia, and Rest of the World, with North America contributing the highest share, followed by Europe. Government funding, increasing opportunities in NGS clinical applications and presence of dominant NGS platform players in U.S. are the main drivers for the North American market. The Asian next generation sequencing market is expected to grow the fastest owing to its growing presence in the sequencing and NGS bioinformatics services market.

The key players in the NGS platforms market include Illumina (U.S.), Life Technologies (Thermo Fisher Scientific) (U.S.), 454 Roche (U.S.), and Pacific Biosciences (U.S.). The NGS bioinformatics/data analysis market is dominated by players like CLC bio (Denmark) (acquired by QIAGEN), Biomatters (New Zealand), Partek (U.S.), Genomatix (Germany), Knome (U.S.), and DNASTAR (U.S.).

Next Generation Sequencing Market

Source: MarketsandMarkets Analysis

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports